More specifically, TNF receptor-associated factor 6 (TRAF6), an E3 ubiquitin ligase that correlates with worse prognosis in DLBCL patients [129], can be SUMOylated and repress gene transcription through HDAC recruitment in B cells (Figure 3) [130]. This evidence concerns the gene TRAF6 and diffuse large B-cell lymphoma.